Article
Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor.
Hormone research in paediatrics - 1 Jan 2024
Park Julie, Walsh Anna, Kerr Sue, Woodland Clare, Southward Suzanne, Deakin Mark, Senniappan Senthil, Thursfield Rebecca
Abstract excerpt
INTRODUCTION: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are increasingly used in children and young people with cystic fibrosis (CF). Data in adults show there may be an impact on glycaemic control in those with CF-related diabetes (CFRD). Paediatric data are rare. Case Series/Presentation: Children aged >12 years with CFRD, who were eligible for elexacaftor/tezacaftor/ivacaftor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.